XRCC1 Arg399Gln and Arg194Trp polymorphisms in childhood acute lymphoblastic leukemia risk: A meta-analysis

Leukemia and Lymphoma

Volumn 54, Issue 1, 2013, Pages 153-159

  Wang, Rensheng ^a   Hu, Xueying ^b   Zhou, Yang ^b   Feng, Qiming ^b   Su, Li ^b   Long, Jianxiong ^b   Wei, Bo ^b  

^a First Affiliated Hospital   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Childhood acute lymphoblastic leukemia; Meta analysis; Polymorphisms; XRCC1

Indexed keywords

XRCC1 PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER RISK; CHILDHOOD LEUKEMIA; DISEASE ASSOCIATION; DNA POLYMORPHISM; EMBASE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; PUBLICATION; SAMPLE SIZE;

AMINO ACID SUBSTITUTION; ASIAN CONTINENTAL ANCESTRY GROUP; DNA-BINDING PROTEINS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ODDS RATIO; POLYMORPHISM, GENETIC; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PUBLICATION BIAS; RISK;

EID: 84870925601     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.704031     Document Type: Article

References (46)

1. Linet MS, Ries LA, Smith MA, et al. Cancer surveillance series: Recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst 1999 ; 91: 1051-1058. (Pubitemid 29293044)
2. Arinc E, Sen A. Eff ects of in vivo benzo(a)pyrene treatment on liver microsomal mixed-function oxidase activities of gilthead seabream (Sparus aurata). Comp Biochem Physiol Pharmacol Toxicol Endocrinol 1994 ; 107: 405-414. (Pubitemid 24107089)
3. Arinc E, Adali O, Gencler-Ozkan AM. Induction of N-nitrosodimethylamine metabolism in liver and lung by in vivo pyridine treatments of rabbits. Arch Toxicol 2000 ; 74: 329-434.
4. Arinc E, Arslan S, Bozcaarmutlu A, et al. Eff ects of diabetes on rabbit kidney and lung CYP2E1 and CYP2B4 expression and drug metabolism and potentiation of carcinogenic activity of N-nitrosodimethylamine in kidney and lung. Food Chem Toxicol 2007 ; 45: 107-118. (Pubitemid 44792320)
5. Davies SM, Robison LL, Buckley JD, et al. Glutathione S-transferase polymorphisms in children with myeloid leukemia: A Children's Cancer Group study. Cancer Epidemiol Biomarkers Prev 2000; 9: 563- 566. (Pubitemid 30396177)
6. N agai F, H iyoshi Y, S ugimachi K, et al. C ytochrome P450 (CYP) expression in human myeloblastic and lymphoid cell lines. Biol Pharm Bull 2002 ; 25: 383-385. (Pubitemid 39663295)
7. Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 1998; 58: 604- 608. (Pubitemid 28099464)
8. B erwick M, V ineis P. M arkers of DNA repair and susceptibility to cancer in humans: An epidemiologic review. J Natl Cancer Inst 2000 ; 92: 874-897. (Pubitemid 30429188)
9. C aldecott KW, A oufouchi S, J ohnson P, et al. X RCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular " nick-sensor " in vitro. Nucleic Acids Res 1996; 24: 4387- 4394. (Pubitemid 26388624)
10. Masson M, Niedergang C, Schreiber V, et al. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol 1998 ; 18: 3563-3571. (Pubitemid 28240528)
11. W hitehouse CJ, T aylor RM, Th istlethwaite A, et al. XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair. Cell 2001 ; 104: 107-117. (Pubitemid 32144976)
12. Vidal AE, Boiteux S, Hickson ID, et al. XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. EMBO J 2001 ; 20: 6530-6539. (Pubitemid 33078725)
13. Lindahl T, Wood RD. Quality control by DNA repair. Science 1999 ; 286: 1897-1905. (Pubitemid 129515891)
14. Abdel-Rahman SZ, El-Zein RA. The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specifi c nitrosamine NNK. Cancer Lett 2000; 159: 63- 71.
15. Lunn RM, Langlois RG, Hsieh LL, et al. XRCC1 polymorphisms: Eff ects on afl atoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 1999; 59: 2557- 2561. (Pubitemid 29269097)
16. Duell EJ, Wiencke JK, Cheng TJ, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 2000 ; 21: 965-971. (Pubitemid 30265141)
17. Fan J, Otterlei M, Wong HK, et al. XRCC1 co-localizes and physically interacts with PCNA. Nucleic Acids Res 2004; 32: 2193- 2201. (Pubitemid 38864686)
18. C analle R, S ilveira VS, A lberto Scrideli C, et al. I mpact of thymidylate synthase promoter and DNA repair gene polymorphisms on susceptibility to childhood acute lymphoblastic leukemia. Leuk Lymphoma 2011; 52: 1118- 1126.
19. Tumer TB, Yilmaz D, Tanrikut C, et al. DNA repair XRCC1 Arg399Gln polymorphism alone, and in combination with CYP2E1 polymorphisms signifi cantly contribute to the risk of development of childhood acute lymphoblastic leukemia. Leuk Res 2010; 34: 1275- 1281.
20. Stanczyk M, Sliwinski T, Cuchra M, et al. The association of polymorphisms in DNA base excision repair genes XRCC1, OGG1 and MUTYH with the risk of childhood acute lymphoblastic leukemia. Mol Biol Rep 2010; 38: 445- 451.
21. Meza-Espinoza JP, Peralta-Leal V, Gutierrez-Angulo M, et al. XRCC1 polymorphisms and haplotypes in Mexican patients with acute lymphoblastic leukemia. Genet Mol Res 2009; 8: 1451- 1458.
22. Batar B, G u ven M, Baris S, et al. DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia. Leuk Res 2009; 33: 759- 763.
23. Celkan T, G u ven M, Batar B, et al. The diff erence between pre-B cell acute lymphoblastic leukemia and Burkitt lymphoma in relation to DNA damage repair gene polymorphisms in childhood. Leuk Lymphoma 2008; 49: 1638- 1640.
24. P akakasama S, S irirat T, K anchanachumpol S, et al. G enetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2007; 48: 16- 20. (Pubitemid 44871587)
25. J oseph T, K usumakumary P, C hacko P, et al. D NA repair gene XRCC1 polymorphisms in childhood acute lymphoblastic leukemia. Cancer Lett 2005 ; 217: 17-24. (Pubitemid 39642862)
26. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986 ; 7: 177-188. (Pubitemid 17189972)
27. Sutton AJ, Abrams KR, Jones DR, et al. Methods for meta-analysis in medical research. Chichester: Wiley; 2000.
28. L au J, I oannidis J, S chmid CH. Q uantitative synthesis in systematic reviews. Ann Intern Med 1997 ; 127: 820-826. (Pubitemid 27465551)
29. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088- 1101.
30. E gger M, D avey Smith G, S chneider M, et al. B ias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629- 634. (Pubitemid 27387172)
31. Tumer TB, Sahin G, Arinc E. Association between polymorphisms of EPHX1 and XRCC1 genes and the risk of childhood acute lymphoblastic leukemia. Arch Toxicol 2012; 86: 431- 439.
32. S crideli CA, T one LG. P olymorphisms of DNA repair genes and susceptibility to acute childhood lymphoblastic leukemia. Leuk Res 2009 ; 33: 745-746.
33. Tumer TB, Yilmaz D, Tanrikut C, et al. DNA repair gene XRCC1 Arg399Gln polymorphism is associated with increased risk of acute lymphoblastic leukemia in Turkish children. Drug Metab Rev 2009 ; 41: 76-77.
34. Zhu R, Wu Y, Lu FJ, et al. Polymorphisms and haplotypes of XRCC1 and APE1 and risk of childhood leukaemia in China: A casecontrol analysis. Eur J Oncol 2008; 13: 187-192.
35. Tang FF, Ouyang J, Xu Y, et al. The relationship between polymorphism of genes XPA, XPC, XPD, XRCC1 and susceptibiltiy to acute lymphoblastic leukemia. Zhonghua Nei Ke Za Zhi 2011 ; 50: 859-862.
36. O zcan A, Pehlivan M, Tomatir AG, et al. Polymorphisms of the DNA repair gene XPD (751) and XRCC1 (399) correlates with risk of hematological malignancies in Turkish population. Afr J Biotechnol 2011 ; 10: 8860-8870.
37. S aadat M, A nsari-Lari M. P olymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures. Breast Cancer Res Treat 2009; 115: 137- 144.
38. W ei B, Z hou Y, X u Z, et al. X RCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: A meta-analysis. Prostate Cancer Prostatic Dis 2011 ; 14: 225-231.
39. Kiyohara C, Takayama K, Nakanishi Y. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: A meta-analysis. Lung Cancer 2006; 54: 267- 283. (Pubitemid 44634141)
40. Wang B, Wang D, Huang G, et al. XRCC1 polymorphisms and risk of colorectal cancer: A meta-analysis. I nt J Colorectal Dis 2010; 2 5: 3 13- 3 21.
41. Liu F, Li B, Wei Y, et al. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: A meta-analysis. Liver Int 2011 ; 31: 802-809.
42. Wang C, Sun Y, Han R. XRCC1 genetic polymorphisms and bladder cancer susceptibility: A meta-analysis. Urology 2008 ; 72: 869-872.
43. Blettner M, Sauerbrei W, Schlehofer B, et al. Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol 1999 ; 28: 1-9. (Pubitemid 29086203)
44. Curtin K, Samowitz WS, Wolff RK, et al. A ssessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer. Cancer Epidemiol Biomarkers Prev 2009 ; 18: 3384-3388.
45. Weng Z, Lu Y, Weng H, et al. Eff ects of the XRCC1 gene-environment interactions on DNA damage in healthy Japanese workers. Environ Mol Mutagen 2008; 49: 708- 719.
46. Huang M, Dinney CP, Lin X, et al. High-order interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility. Cancer Epidemiol Biomarkers Prev 2007; 16: 84- 91. (Pubitemid 46174268)